Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.

Saved in:
Bibliographic Details
Title: Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
Authors: Sundquist E; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu FI-90014, Finland.; Medical Research Centre, Oulu University Hospital, Oulu FI-90014, Finland., Kauppila JH; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu FI-90014, Finland.; Medical Research Centre, Oulu University Hospital, Oulu FI-90014, Finland.; Department of Molecular Medicine and Surgery, Upper Gastrointestinal Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm 17176, Sweden., Veijola J; Department of Physiology, Institute of Biomedicine, University of Oulu, Oulu FI-90014, Finland.; Department of Biochemistry and Molecular Medicine, University of Oulu and Biocenter Oulu, Oulu FI-90014, Finland., Mroueh R; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki FI-00014, Finland., Lehenkari P; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu FI-90014, Finland.; Medical Research Centre, Oulu University Hospital, Oulu FI-90014, Finland., Laitinen S; Department of Research and Development, Finnish Red Cross Blood Service, Helsinki FI-00014, Finland., Risteli J; Medical Research Centre, Oulu University Hospital, Oulu FI-90014, Finland.; Department of Clinical Chemistry, Institute of Diagnostics, University of Oulu, Oulu FI-90014, Finland.; Northern Laboratory Centre NordLab, Oulu FI-90220, Finland., Soini Y; Department of Clinical Pathology and Forensic Medicine, University of Eastern Finland, Kuopio FI-70211, Finland.; Cancer Centre of Eastern Finland and Kuopio University Hospital, Kuopio FI-70210, Finland., Kosma VM; Department of Clinical Pathology and Forensic Medicine, University of Eastern Finland, Kuopio FI-70211, Finland.; Cancer Centre of Eastern Finland and Kuopio University Hospital, Kuopio FI-70210, Finland.; Department of Clinical Pathology, Imaging Centre, Kuopio University Hospital, Kuopio FI-70211, Finland., Sawazaki-Calone I; Oral Pathology and Oral Medicine, Dentistry School, Western Paraná State University, Cascavel 85819-110, Brazil., Macedo CC; Department of Oral Diagnosis, Oral Pathology Division, Piracicaba Dental School, University of Campinas, Campinas 13414-903, Brazil., Bloigu R; Medical Informatics and Statistics Research Group, University of Oulu, Oulu FI-90014, Finland., Coletta RD; Department of Oral Diagnosis, Oral Pathology Division, Piracicaba Dental School, University of Campinas, Campinas 13414-903, Brazil., Salo T; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu FI-90014, Finland.; Medical Research Centre, Oulu University Hospital, Oulu FI-90014, Finland.; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki FI-00014, Finland.
Source: British journal of cancer [Br J Cancer] 2017 Feb 28; Vol. 116 (5), pp. 640-648. Date of Electronic Publication: 2017 Jan 17.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/bjc.2016.455